Information Provided By: 
Fly News Breaks for May 21, 2018
MDSO
May 21, 2018 | 07:16 EDT
As previously reported, Morgan Stanley analyst Brian Essex downgraded Medidata to Equal Weight from Overweight, stating that he thinks its product momentum continues, but he sees more attractive opportunities elsewhere in the space given the recent run-up in the shares. Essex did not change his estimates for Medidata and maintains a $79 price target on the stock.
News For MDSO From the Last 2 Days
There are no results for your query MDSO
